Clinical Trial Detail

NCT ID NCT03032484
Title TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The University of Texas Health Science Center at San Antonio
Indications

astrocytoma

Therapies

Bevacizumab

Bevacizumab + TVB-2640

Age Groups: adult senior

No variant requirements are available.